Cargando…

The optogenetic promise for oncology: Episode I

As light-based control of fundamental signaling pathways is becoming a reality, the field of optogenetics is rapidly moving beyond neuroscience. We have recently developed receptor tyrosine kinases that are activated by light and control cell proliferation, epithelial–mesenchymal transition, and ang...

Descripción completa

Detalles Bibliográficos
Autores principales: Ingles-Prieto, Alvaro, Reichhart, Eva, Schelch, Karin, Janovjak, Harald, Grusch, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905200/
https://www.ncbi.nlm.nih.gov/pubmed/27308360
http://dx.doi.org/10.4161/23723548.2014.964045
_version_ 1782437227818647552
author Ingles-Prieto, Alvaro
Reichhart, Eva
Schelch, Karin
Janovjak, Harald
Grusch, Michael
author_facet Ingles-Prieto, Alvaro
Reichhart, Eva
Schelch, Karin
Janovjak, Harald
Grusch, Michael
author_sort Ingles-Prieto, Alvaro
collection PubMed
description As light-based control of fundamental signaling pathways is becoming a reality, the field of optogenetics is rapidly moving beyond neuroscience. We have recently developed receptor tyrosine kinases that are activated by light and control cell proliferation, epithelial–mesenchymal transition, and angiogenic sprouting—cell behaviors central to cancer progression.
format Online
Article
Text
id pubmed-4905200
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-49052002016-06-15 The optogenetic promise for oncology: Episode I Ingles-Prieto, Alvaro Reichhart, Eva Schelch, Karin Janovjak, Harald Grusch, Michael Mol Cell Oncol Author's View As light-based control of fundamental signaling pathways is becoming a reality, the field of optogenetics is rapidly moving beyond neuroscience. We have recently developed receptor tyrosine kinases that are activated by light and control cell proliferation, epithelial–mesenchymal transition, and angiogenic sprouting—cell behaviors central to cancer progression. Taylor & Francis 2014-10-29 /pmc/articles/PMC4905200/ /pubmed/27308360 http://dx.doi.org/10.4161/23723548.2014.964045 Text en © 2014 The Author(s). Published with license by Taylor & Francis Group, LLC http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted.
spellingShingle Author's View
Ingles-Prieto, Alvaro
Reichhart, Eva
Schelch, Karin
Janovjak, Harald
Grusch, Michael
The optogenetic promise for oncology: Episode I
title The optogenetic promise for oncology: Episode I
title_full The optogenetic promise for oncology: Episode I
title_fullStr The optogenetic promise for oncology: Episode I
title_full_unstemmed The optogenetic promise for oncology: Episode I
title_short The optogenetic promise for oncology: Episode I
title_sort optogenetic promise for oncology: episode i
topic Author's View
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905200/
https://www.ncbi.nlm.nih.gov/pubmed/27308360
http://dx.doi.org/10.4161/23723548.2014.964045
work_keys_str_mv AT inglesprietoalvaro theoptogeneticpromiseforoncologyepisodei
AT reichharteva theoptogeneticpromiseforoncologyepisodei
AT schelchkarin theoptogeneticpromiseforoncologyepisodei
AT janovjakharald theoptogeneticpromiseforoncologyepisodei
AT gruschmichael theoptogeneticpromiseforoncologyepisodei
AT inglesprietoalvaro optogeneticpromiseforoncologyepisodei
AT reichharteva optogeneticpromiseforoncologyepisodei
AT schelchkarin optogeneticpromiseforoncologyepisodei
AT janovjakharald optogeneticpromiseforoncologyepisodei
AT gruschmichael optogeneticpromiseforoncologyepisodei